MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $994,520 | -28.8% | 99,452 | -11.5% | 0.00% | -100.0% |
| Q2 2023 | $1,396,523 | +173.2% | 112,351 | +207.9% | 0.00% | – |
| Q1 2023 | $511,225 | -34.1% | 36,490 | -32.7% | 0.00% | – |
| Q4 2022 | $775,488 | -74.7% | 54,192 | -54.8% | 0.00% | -100.0% |
| Q3 2022 | $3,061,000 | -56.7% | 119,880 | -51.9% | 0.00% | -66.7% |
| Q2 2022 | $7,077,000 | -55.9% | 249,101 | -45.3% | 0.00% | -50.0% |
| Q1 2022 | $16,056,000 | +165.4% | 455,221 | +215.3% | 0.01% | +200.0% |
| Q4 2021 | $6,049,000 | +129.7% | 144,363 | +169.0% | 0.00% | +100.0% |
| Q3 2021 | $2,634,000 | +43.2% | 53,669 | +21.8% | 0.00% | 0.0% |
| Q2 2021 | $1,839,000 | +47.1% | 44,069 | +25.7% | 0.00% | 0.0% |
| Q1 2021 | $1,250,000 | – | 35,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |